MSH2 and Lynch syndrome: Lynch syndrome is a cancer risk disease characterized by a monoallelic germline mutation in a mismatch repair (MMR) gene, particularly MLH1, MSH2/6, or PMS2, or by a germline deletion inside epithelial cell adhesion molecule (EpCAM) that contributes to epigenetic silencing of the neighboring MSH2 gene (52).